Perry W. Buffington – Psychopharmacology 2-Day Conference
Course Description
Archive : Perry W. Buffington – Psychopharmacology 2-Day Conference Digital Download
Salepage : Perry W. Buffington – Psychopharmacology 2-Day Conference
Delivery : Online With Any Device
- Faculty:
- Perry W. Buffington
- Duration:
- 12 Hours 12 Minutes
- Format:
- Audio and Video
- Copyright:
- Sep 14, 2017
Description
Handouts
| Manual ZNM048500 (2.97 MB) | 121 Pages | Available after Purchase |
Outline
DAY ONE
PSYCHOPHARMACOLOGY
- Historical antecedents of modern psychopharmacology
- Diagnostic issues
- Clarification of terms
- Drug metabolism concepts: pharmacokinetics & pharmacodynamics
- Drug mechanism of action
- Placebo & Nocebo
- Pharmacotherapy vs. Pharmacotherapy
- Developing highly effective collaborations with prescribers
DEPRESSIVE DISORDERS
- Biogenic Amine, Cortisol, Down-Regulation, & Neurotropic Hypotheses
- Neurochemistry of depression
- Types of anti-depressants
- Preventing side effects
- Tardive Dysphoria: real or imagined?
ANXIETY DISORDERS & OBSESSIVE COMPULSIVE DISORDERS & TRAUMA RELATED DISORDERS
- Neurochemistry of anxiety
- GAD, panic disorders, phobias
- OCD
- PTSD
- Physiological interventions
- Anti-anxiety medications
- Anti-depressants
- Non-pharmacologic options
- Benzodiazepines: risks and benefits
- Preventing side effects
BIPOLAR DISORDERS
- Neurochemistry
- The Bipolar Spectrum & DSM-5 Ā® Changes
- Mood stabilizers
- Lithium
- Anti-convulsants & neuromodulators
- Typical, atypical, & third-generation antipsychotics
- Effective strategies for improving outcomes for clients
PSYCHOTIC DISORDERS/ SCHIZOPHRENIA
- Neurochemistry of psychosis and schizophrenia
- Antipsychotic Medications:
- First generation (typical)
- Second generation (atypical)
- Managing side effects
- Extrapyramidal symptoms and TD
- Metabolic problems- what blood tests are needed and when
- Preventing Diabetes Mellitus
- Recognizing hyperprolactinemia- and why you need to know
- Use of atypical antipsychotics for multiple disorders
LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS
DAY TWO
ATTENTIONAL DISORDERS
- Differential diagnosis
- Neurochemistry of ADHD
- Treatment controversies
- Substance abuse and ADHD
- Stimulant medications
- Non-stimulant options
- Preventing side effects
SUBSTANCE ABUSE DISORDERS
- Neurochemistry of addiction
- Negative reinforcement & creation of habits
- Alcohol
- Caffeine
- Nicotine
- Cannabis
- Opiates
- PCP & Ketamine
- MDMA (Ecstasy)
- Energy vs. Chill Drinks
- Over-the-counter & herbal psychopharmacology
- Addiction treatments
- Behavioral addictions
SPECIAL POPULATIONS
- Specialized guidelines for geriatric patients
- Dementia treatment
- Slow vs. rapid metabolizers (genetic polymorphisms)
TREATING CLIENTS PAIN
- Acute vs. chronic pain
- Alternatives to pharmacology
- Pain vs. depression: which comes first?
ETHICS & PSYCHOPHARMACOLOGY
- High-risk pharmacology & psychopharmacology
- Off-label use of medications
- Prescribing for children
- Elective psychopharmacology
- Marketing of mental illness
- Polypharmacy
- Informed vs. uninformed consent
- Patient & third party pressures
- Professional boundaries
- Ethics associated with medical errors
- Role of placebo
FUTURE TRENDS
- Change of mind: preventing vs. managing side effects
- Medicalization of normal
- Computer assisted devices
- New meds, new diagnoses, new theories, new normal
- Top 10 Medical Emergencies
- Integrating psychotherapy with psychopharmacology
LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS
Faculty
Perry W. Buffington, PH.D., MS Related seminars and products: 2
Perry Buffington, Ph.D., M.S., Ā has over 20 years of experience in the medical consulting field and is currently a full-time senior lecturer at the University of Georgia, teaching psychopharmacology at the undergraduate and graduate levels. He is former chairman of the prestigious Florida Psychological Association’s Prescriptive Authority Committee and teaches seminars nationwide on minimizing psychopharmacological errors.
As the author of eight books (currently working on his first psychopharmacology text), his by-line has appeared in hundreds of periodicals including the Ā Saturday Evening Post, USA Today, Ā and Ā Success. Ā He is the former contributing editor for Delta Air Lines’ in-flight magazine, Ā Sky, Ā and served as a syndicated newspaper/web columnist for Universal Press. Additional, he hosted his own radio show, syndicated nationally, by Envison Radio Networks.
Perry’s presentation style is engaging, a blend of education and entertainment; as a result, critics (and especially his students) applaud his ability to make complicated topics understandable and applicable -Ā even useful!!
Speaker Disclosures:
Financial: Perry Buffington is the President of Go-Buff Enterprises, Inc. He is a member of the psychology faculty, Franklin College of Arts & Sciences, The University of Georgia. Dr. Buffington receives a speaking honorarium from PESI, Inc.
Nonfinancial: Perry Buffington has no relevant nonfinancial relationship to disclose.
More from Categories : Health & Fitness
Reviews
There are no reviews yet.